Vyome Holdings, Inc.
HINDNASDAQHealthcare● Active
$2.19
+$0.03(+1.39%)
Market Cap$12330815
P/E Ratio—
52W High$20.76
52W Low$1.75
Vyome Holdings, Inc. (HIND) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HIND · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$0.15
Est. -$0.15 · +0.0%
Revenue
$0.00B
Est. $0.00B · +0.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
✓ 2-Quarter EPS Beat Streak
HIND reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.19 | — | — | — | $0.00B | — |
| — Q2 FY2026 | May 12, 2026 | -$0.15 | -$0.15 | +0.0% | $0.00B | $0.00B | +0.0% |
| — Q1 FY2026 | Mar 26, 2026 | -$0.47 | -$0.47 | +0.0% | $0.00B | $0.00B | +0.0% |
| ▼ Q4 FY2025 | Nov 14, 2025 | -$0.11 | -$3.12 | -2736.4% | $0.00B | — | — |
| — Q3 FY2025 | Aug 14, 2025 | — | -$2.25 | — | $0.00B | — | — |
| — Q2 FY2025 | May 20, 2025 | — | $18.98 | — | $0.00B | — | — |
| ▲ Q2 FY2025 | Apr 4, 2025 | -$101.50 | -$47.25 | +53.5% | $0.00B | $0.00B | -43.1% |
| ▲ Q4 FY2024 | Nov 14, 2024 | -$5.80 | -$3.11 | +46.4% | $0.00B | $0.00B | -8.6% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.19
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026
EPS Actual
-$0.15
EPS Est.
-$0.15
EPS Surpr.
+0.0%
Revenue
$0.00B
Q1 FY2026
Mar 26, 2026
EPS Actual
-$0.47
EPS Est.
-$0.47
EPS Surpr.
+0.0%
Revenue
$0.00B
Q4 FY2025
Nov 14, 2025Miss
EPS Actual
-$3.12
EPS Est.
-$0.11
EPS Surpr.
-2736.4%
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025
EPS Actual
-$2.25
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
May 20, 2025
EPS Actual
$18.98
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
Apr 4, 2025Beat
EPS Actual
-$47.25
EPS Est.
-$101.50
EPS Surpr.
+53.5%
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024Beat
EPS Actual
-$3.11
EPS Est.
-$5.80
EPS Surpr.
+46.4%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.29 | $-0.29 | $-0.29 | 1 |
| Q3 FY2027 | $-0.28 | $-0.28 | $-0.28 | 1 |
| Q2 FY2027 | $-0.26 | $-0.26 | $-0.26 | 1 |
| Q1 FY2027 | $-0.25 | $-0.25 | $-0.25 | 1 |
| Q4 FY2026 | $-0.24 | $-0.24 | $-0.24 | 1 |
| Q3 FY2026 | $-0.21 | $-0.21 | $-0.21 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 12, 2026 | +0.0% | $1.97 | $1.98 | +0.51% |
| ▲ Q1 FY2026 | Mar 26, 2026 | +0.0% | $2.27 | $2.20 | -3.08% |
| ▼ Q4 FY2025 | Nov 14, 2025 | -2736.4% | $4.93 | $4.87 | -1.22% |
| — Q3 FY2025 | Aug 14, 2025 | — | $12.80 | $15.68 | +22.50% |
| — Q2 FY2025 | May 20, 2025 | — | $25.88 | $23.68 | -8.50% |
| ▲ Q2 FY2025 | Apr 4, 2025 | +53.5% | $37.96 | $46.00 | +21.18% |
| ▲ Q4 FY2024 | Nov 14, 2024 | +46.4% | $562.00 | $517.00 | -8.01% |
| ▲ Q3 FY2024 | Aug 14, 2024 | +49.9% | $1,009.00 | $1,032.00 | +2.28% |
Q2 FY2026+0.51%
Report Date
May 12, 2026
EPS Beat/Miss
+0.0%
Price Before
$1.97
Price After
$1.98
Q1 FY2026-3.08%
Report Date
Mar 26, 2026
EPS Beat/Miss
+0.0%
Price Before
$2.27
Price After
$2.20
Q4 FY2025-1.22%
Report Date
Nov 14, 2025
EPS Beat/Miss
-2736.4%
Price Before
$4.93
Price After
$4.87
Q3 FY2025+22.50%
Report Date
Aug 14, 2025
EPS Beat/Miss
—
Price Before
$12.80
Price After
$15.68
Q2 FY2025-8.50%
Report Date
May 20, 2025
EPS Beat/Miss
—
Price Before
$25.88
Price After
$23.68
Q2 FY2025+21.18%
Report Date
Apr 4, 2025
EPS Beat/Miss
+53.5%
Price Before
$37.96
Price After
$46.00
Q4 FY2024-8.01%
Report Date
Nov 14, 2024
EPS Beat/Miss
+46.4%
Price Before
$562.00
Price After
$517.00
Q3 FY2024+2.28%
Report Date
Aug 14, 2024
EPS Beat/Miss
+49.9%
Price Before
$1,009.00
Price After
$1,032.00
Avg Beat Reaction+2.58%
Avg Miss Reaction-1.22%
Beat Rate5 / 8 quarters
Largest Move+22.50% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HIND ends December
Vyome Holdings, Inc. (HIND) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.15 (in line with the analyst consensus of $-0.15). HIND has beaten EPS estimates for 2 consecutive quarters. The next HIND earnings date is expected around September 1, 2026.
Each quarter, investors track HIND earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HIND revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HIND's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HIND earnings · 4 questionsVyome Holdings, Inc.'s next earnings report is expected around September 1, 2026. HIND typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HIND historically reports after market close (AMC).
HIND earnings datewhen is HIND earningsHIND next earnings datewhen does HIND report earningsHIND earnings calendar
▸ Source: FMP · Vyome Holdings, Inc. SEC filings · US GAAP · Vyome Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026